![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 317/26 | (2006.01) |
C07D 317/42 | (2013.01) | ||
C07D 493/08 | (2006.01) | ||
C07D 493/08 | (2013.01) | ||
C07D 317/42 | (2006.01) | ||
C07D 317/26 | (2013.01) | ||
A61K 31/70 | (2006.01) |
(11) | Number of the document | 3466431 |
(13) | Kind of document | T |
(96) | European patent application number | 18201632.9 |
Date of filing the European patent application | 2014-03-10 | |
(97) | Date of publication of the European application | 2019-04-10 |
(45) | Date of publication and mention of the grant of the patent | 2023-11-15 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
201361783128 P | 2013-03-14 | US | |
201361887504 P | 2013-10-07 | US | |
201361912252 P | 2013-12-05 | US |
(72) |
Brenek, Steven J. , US
Caron, Stephanie , US
Nelson, Jade D. , US
Webster, Mark, E. , US
Weekly, Rodney Matthew , US
|
(73) |
MSD International GmbH ,
Weystrasse 20, 6000 Luzern,
CH
|
(54) | CRYSTALLINE FORMS AND METHODS FOR PREPARING SGLT2 INHIBITORS |
CRYSTALLINE FORMS AND METHODS FOR PREPARING SGLT2 INHIBITORS |